Search

Your search keyword '"Van Wyk J"' showing total 1,274 results

Search Constraints

Start Over You searched for: Author "Van Wyk J" Remove constraint Author: "Van Wyk J"
1,274 results on '"Van Wyk J"'

Search Results

1. Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care

3. Saccharification of Different Delignified Sawdust Masses from Various Trees Along the Lagos Lagoon in Nigeria.

5. Temperature-related Saccharification of Delignified Sawdust Materials from the Lagos Lagoon in Nigeria.

7. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

9. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

11. Spondylo-ocular syndrome: anaesthetic concerns and considerations for a novel genetic syndrome - a case report.

16. Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

18. Saccharification of Various Wastepaper Materials by Cellulase from Brown Garden Snail (Cornu aspersum) at Different Incubation pH Values.

19. Enhancing the enzymatic browning inhibition capacity of Moringa oleifera seed extract via the Maillard reaction

25. Switching to the 2-drug regimen of dolutegravir/lamivudine (DTG/3TC) fixed-dose combination (FDC) is non-inferior to continuing a 3-drug regimen through 24 weeks in a randomized clinical trial (SALSA)

26. The knowledge and attitudes of final-year medical students regarding care of older patients

32. Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With HIV-1: Results Through Week 144 From the Phase 3, Non-inferiority TANGO Randomized Trial

33. Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy-Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review

34. The Impact of University Incorporation on College Lecturers

36. Fusarium chuoi R. Hill, Gaya, D.T. Vu, Sand.-Den. & Crous, R. Hill, Gaya, D.T. Vu, Sand.-Den. & Crous sp. nov

37. Fusarium chuoi Crous, Osieck, Jurjevi, Boers, Iperen, Starink-Willemse, Dima, Balashov, Bulgakov, Johnston, Morozova, Pinruan, Sommai, Alvarado, Decock, Lebel, McMullan-Fisher, Moreno, Shivas, Zhao, Abdollahzadeh, Abrinbana, Ageev, Akhmetova, Alexandrova, Altés, Amaral, Angelini, Antonín, Arenas, Asselman, Badali, Baghela, Bañares, Barreto, Baseia, Bellanger, Berraf-Tebbal, Biketova, Bukharova, Burgess, Cabero, Câmara, Cano-Lira, Ceryngier, Chávez, Cowan, Lima, Oliveira, Denman, Dang, Dovana, Duarte, Eichmeier, Erhard, Esteve-Raventós, Fellin, Ferisin, Ferreira, Ferrer, Finy, Gaya, Geering, Gil-Durán, Glässnerová, Glushakova, Gramaje, Guard, Guarnizo, Haelewaters, Halling, Hill, Hirooka, Hubka, Iliushin, Ivanova, Ivanushkina, Jangsantear, Justo, Kachalkin, Kato, Khamsuntorn, Kirtsideli, Knapp, Kochkina, Koukol, Kovács, Kruse, Kumar, Kušan, Læssøe, Larsson, Lebeuf, Levicán, Loizides, Marinho, Luangsa-ard, Lukina, Magaña-Dueñas, Maggs-Kölling, Malysheva, Malysheva, Martín, Martín, Matočec, McTaggart, Mehrabi-Koushki, Mešić, Miller, Mironova, Moreau, Morte, Müller, Nagy, Nanu, Navarro-Ródenas, Nel, Nguyen, Nóbrega, Noordeloos, Olariaga, Overton, Ozerskaya, Palani, Pancorbo, Papp, Pawłowska, Pham, Phosri, Popov, Portugal, Pošta, Reschke, Reul, Ricci, Rodríguez, Romanowski, Ruchikachorn, Saar, Safi, Sakolrak, Salzmann, Sandoval-Denis, Sangwichein, Sanhueza, Sato, Sastoque, Senn-Irlet, Shibata, Siepe, Somrithipol, Spetik, Sridhar, Stchigel, Stuskova, Suwannasai, Tan, Thangavel, Tiago, Tiwari, Tkalčec, Tomashevskaya, Tonegawa, Tran, Tran, Trovão, Trubitsyn, Wyk, Vieira, Vila, Visagie, Vizzini, Volobuev, Vu, Wangsawat, Yaguchi, Ercole, Ferreira, Souza, Vieira & Groenewald, 2021, sp. nov

38. Fungal Planet description sheets: 1284–1382

39. Comparison of viral replication for the 2-drug regimen (2DR) of dolutegravir/lamivudine (DTG/3TC) versus a 3/4-drug tenofovir alafenamide-based regimen (TBR) in the TANGO study through week 96

43. Fungal Planet description sheets: 1284–1382

44. Fungal Planet description sheets: 1284–1382

45. Fungal Planet description sheets:1284-1382

46. HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review

47. Weight gain following antiretroviral therapy (ART) initiation in ART-naïve people living with HIV in the current treatment era

Catalog

Books, media, physical & digital resources